Gabrielle Alison Silver, Director at OPIANT PHARMACEUTICALS, INC. (OPNT), bought 1,785 shares at $13.51 ($24K) on 2019-11-22, disclosed to the SEC on 2019-11-25.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| OPNT | BUY | 2020-06-12 | $25K | — | Filing → |